Next Few Years Will Bring Immunotherapy to the Forefront of Therapy for Urothelial Carcinoma – Targeted Oncology
|
Next Few Years Will Bring Immunotherapy to the Forefront of Therapy for Urothelial Carcinoma
Targeted Oncology Although the success of immunotherapy has made a significant impact in the field of urothelial carcinoma, an unmet need still lies in the fact that these agents only provide a clinical benefit for approximately 1 out of every 3 patients, says Evan Y … |
